Incremental healthcare costs attributable to type 2 diabetes in Hong Kong: A population-based cost of illness study

Diabet Med. 2023 Feb;40(2):e14970. doi: 10.1111/dme.14970. Epub 2022 Oct 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cost of Illness
  • Cost-Benefit Analysis
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / epidemiology
  • Health Care Costs
  • Hong Kong / epidemiology
  • Humans